Skip to main content
Clinical Trials/NCT02688010
NCT02688010CompletedNot Applicable

Effect of Reduced Noise Levels and Cycled Light on Visual and Neural Development in Preterm Infants

Children's Hospital of Fudan University1 site in 1 country109 target enrollmentStarted: January 8, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
109
Locations
1
Primary Endpoint
Flash visual evoked potentials (FVEP) at 4 weeks of age

Study Overview

Brief Summary

Noise is a hazard for newborn. In 1997, the American Academy of Pediatrics determined that safe sound levels in the neonatal intensive care unit (NICU) should not exceed 45 dB which has been rarely achieved. High intensities of noise have several negative effects on preterm newborns. Also, they are exposed to either continuous bright light continuous near darkness or unstructured combination of the two during their hospitalizations. The investigators primary objective is to determine the impact of reduced noise levels and cycled light on growth parameters and visual development in preterm infants.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
1 Day to 7 Days (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •<37 gestational weeks preterm infants and >1250g birth weight

Exclusion Criteria

  • •Major congenital anomaly and infection prior to enrolment
  • •Infants with surgical issues

Arms & Interventions

Control

No Intervention

No specific noise reduction strategies to restrict noise exposure less than 45 dB combined with either continuous bright light or continuous near darkness or unstructured combination of the two during the hospitalization.

Noise reduction and cycled light

Experimental

Reduced noise exposure (sound levels <45 dB) and cycled light (approximately 12 hours of light on and 12 hours of light off).

Intervention: Noise reduction and cycled light (Behavioral)

Outcomes

Primary Outcomes

Flash visual evoked potentials (FVEP) at 4 weeks of age

Time Frame: at 4 weeks of age

FVEP is recorded from each eye individually after they fall asleep. Three silver-sliver chloride electrodes are placed according to 10-20 International system with active electrode at Oz (1-2 cm above inion), reference electrode at Fz and ground electrode at Cz. Scalp-electrode impedance is usually below 5kΩ but always below 10kΩ. Flash stimulus (2 Hz.) is given by light emitting diode goggles simulator at a distance of 2 cm to one eye at a time. 100 responses are averaged for each eye automatically in the Nicolet Viking Quest visual electrophysiological device at 1s total sweep time. Band pass filters are set at 0.1-75 Hz. The reproducibility of the responses is ensured by repeating the test two or more times. Responses with excessive artifacts are automatically rejected. The parameters of P1, N1, P2, N2, P3, and N3 of the FVEP are stored and subsequently assessed by ophthalmologist blinded to the infant's clinical course.

Bayley Scales of Infant Development, Second Edition (BSID-III) at 18 months of age

Time Frame: at 18 months of age

Neurodevelopment outcome is measured with the Bayley Scales of Infant Development, Second Edition (BSID-III) at corrected gestational age of 18 month, assessed by the physician from department of child health care who was blinded with respect to the subjects. Mental and motor scores were calculated by the BSID-III Mental Developmental Index (MDI) and Psychomotor Developmental Index (PDI). The subject's neurodevelopmental outcome was classified as delayed if either score was less than 70.

Secondary Outcomes

  • Time to establish full enteral feeding(birth till discharge from hospital (up to 3 months))
  • Incidence of nosocomial infection(up to 3 months)
  • Incidence of intraventricular hemorrhage(1 month)
  • Incidence of retinopathy of prematurity(up to 3 months)
  • Weight at discharge(birth till discharge from hospital (up to 3 months))
  • Head circumferences at discharge(up to 3 months)
  • Incidence of bronchopulmonary dysplasia(at corrected gestational age of 36 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials